ZA200607152B - Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug - Google Patents

Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug

Info

Publication number
ZA200607152B
ZA200607152B ZA200607152A ZA200607152A ZA200607152B ZA 200607152 B ZA200607152 B ZA 200607152B ZA 200607152 A ZA200607152 A ZA 200607152A ZA 200607152 A ZA200607152 A ZA 200607152A ZA 200607152 B ZA200607152 B ZA 200607152B
Authority
ZA
South Africa
Prior art keywords
agonists
drug
production
enantiomerically pure
pure beta
Prior art date
Application number
ZA200607152A
Inventor
Konetzki Ingo
Lustenberger Philipp
Sieger Peter
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200607152(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA200607152B publication Critical patent/ZA200607152B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200607152A 2004-05-14 2006-08-28 Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug ZA200607152B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004024454A DE102004024454A1 (en) 2004-05-14 2004-05-14 Novel enantiomerically pure beta agonists, process for their preparation and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
ZA200607152B true ZA200607152B (en) 2008-04-30

Family

ID=34966720

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200607152A ZA200607152B (en) 2004-05-14 2006-08-28 Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug

Country Status (20)

Country Link
EP (1) EP1789405B1 (en)
JP (1) JP2007537196A (en)
KR (1) KR101270447B1 (en)
CN (4) CN101133039A (en)
AU (1) AU2005243469B2 (en)
BR (1) BRPI0511102B1 (en)
CA (1) CA2562859C (en)
CY (1) CY1114702T1 (en)
DE (1) DE102004024454A1 (en)
DK (1) DK1789405T3 (en)
ES (1) ES2431118T3 (en)
IL (1) IL179217A (en)
MX (1) MXPA06013218A (en)
NZ (1) NZ551416A (en)
PL (1) PL1789405T3 (en)
PT (1) PT1789405E (en)
RU (1) RU2378262C2 (en)
SI (1) SI1789405T1 (en)
WO (1) WO2005111005A1 (en)
ZA (1) ZA200607152B (en)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004024452A1 (en) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for the inhalation of beta agonists
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004054054A1 (en) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines
DE102005007654A1 (en) 2005-02-19 2006-08-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting betamimetics for the treatment of respiratory diseases
DE102005035891A1 (en) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8- (3-amino-piperidin-1-yl) -xanthines, their preparation and their use as pharmaceuticals
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
WO2007017670A1 (en) 2005-08-08 2007-02-15 Argenta Discovery Ltd. Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
MX2008001976A (en) * 2005-08-15 2008-03-25 Boehringer Ingelheim Int Method for producing betamimetics.
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
JP2009526817A (en) * 2006-02-16 2009-07-23 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Pharmaceutical composition for the treatment of respiratory diseases
PE20080142A1 (en) 2006-03-15 2008-04-14 Boehringer Ingelheim Int ENANTHOMERICALLY PURE BETA-AGONISTS AND THEIR PREPARATION PROCEDURES
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
CA2810839A1 (en) 2006-05-04 2007-11-15 Boehringer Ingelheim International Gmbh A polymorphic form of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(r)-amino-piperidin-1-yl)-xanthine
PE20110235A1 (en) 2006-05-04 2011-04-14 Boehringer Ingelheim Int PHARMACEUTICAL COMBINATIONS INCLUDING LINAGLIPTIN AND METMORPHINE
UY30542A1 (en) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int AEROSOL FORMULATION FOR INHALATION OF BETA AGONISTS
PE20080610A1 (en) 2006-08-22 2008-07-15 Boehringer Ingelheim Int NEW ENANTHOMERICALLY PURE BETA-AGONISTS, PROCEDURES FOR THEIR PREPARATION AND USE AS MEDICINES
JP5409387B2 (en) * 2007-01-25 2014-02-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Method for producing β-mimetic
WO2009059893A1 (en) * 2007-11-05 2009-05-14 Boehringer Ingelheim International Gmbh Crystalline hydrate of betamimetika and use as medicament thereof
EP2093219A1 (en) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Crystalline enantiomer free salt form of a betamimetic and its use as medicine
PE20091730A1 (en) 2008-04-03 2009-12-10 Boehringer Ingelheim Int FORMULATIONS INVOLVING A DPP4 INHIBITOR
BRPI0916997A2 (en) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh DPP-4 INHIBITOR AND ITS USE
UY32030A (en) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "TREATMENT FOR DIABETES IN INAPPROPRIATE PATIENTS FOR THERAPY WITH METFORMIN"
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
CN102149407A (en) 2008-09-10 2011-08-10 贝林格尔.英格海姆国际有限公司 Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
BRPI0923121A2 (en) 2008-12-23 2015-08-11 Boehringer Ingelheim Int Saline forms of organic compounds
EA019441B1 (en) 2008-12-30 2014-03-31 Палмаджен Терепьютикс (Инфлеммейшн) Лимитед Sulfonamide compounds for the treatment of respiratory disorders
AR074990A1 (en) 2009-01-07 2011-03-02 Boehringer Ingelheim Int TREATMENT OF DIABETES IN PATIENTS WITH AN INAPPROPRIATE GLUCEMIC CONTROL THROUGH METFORMIN THERAPY
WO2010150014A1 (en) 2009-06-24 2010-12-29 Pulmagen Therapeutics (Inflammation) Limited 5r- 5 -deuterated glitazones for respiratory disease treatment
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
CN107115530A (en) 2009-11-27 2017-09-01 勃林格殷格翰国际有限公司 Gene diabetes mellitus type utilizes the treatment of DPP IV inhibitor such as BI 1356
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
GB201002243D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB201002224D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
KR101927068B1 (en) 2010-05-05 2018-12-10 베링거 인겔하임 인터내셔날 게엠베하 Sequential Combination Therapy by the Weight Reducing Treatment Followed by the DPP-4 Inhibitor
CN102971005A (en) 2010-06-24 2013-03-13 贝林格尔.英格海姆国际有限公司 Diabetes therapy
WO2012022796A2 (en) * 2010-08-20 2012-02-23 Boehringer Ingelheim International Gmbh Novel combinations
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
EP3517539B1 (en) 2011-07-15 2022-12-14 Boehringer Ingelheim International GmbH Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP2906218B1 (en) 2012-10-09 2016-12-14 Boehringer Ingelheim International GmbH Beta-2-adrenoceptor agonist for the treatment of cough
CN102993116A (en) * 2012-12-04 2013-03-27 常州大学 Preparation method of benzoxazine excitant
CA2919776A1 (en) * 2013-08-08 2015-02-12 Galapagos Nv Thieno[2,3-c]pyrans as cftr modulators
JP6615109B2 (en) 2014-02-28 2019-12-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Medical use of DPP-4 inhibitors
CA3022202A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin
CN110062625A (en) 2016-12-12 2019-07-26 勃林格殷格翰国际有限公司 Nintedanib by giving the method for treating interstitial lung disease with Ao Dateluo altogether
CN110114346B (en) * 2016-12-20 2023-10-31 Inke股份公司 Improved process for preparing R-6-hydroxy-8- [ 1-hydroxy-2- [2- (4-methoxyphenyl) -1, 1-dimethylethylaminoethyl ] -2H-1, 4-benzoxazin-3 (4H) -one hydrochloride
CN108822054B (en) * 2018-08-06 2021-06-22 上海方予健康医药科技有限公司 Oxydterol hydrochloride crystal form C and preparation method thereof
CN109096218B (en) * 2018-08-06 2020-10-27 上海方予健康医药科技有限公司 Oxydterol hydrochloride crystal form A and preparation method thereof
CN108997248B (en) * 2018-08-06 2023-08-01 上海方予健康医药科技有限公司 Crystal form B of ondarot hydrochloride and preparation method thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656168A (en) * 1980-12-23 1987-04-07 Merck & Co., Inc. (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
DE3134590A1 (en) * 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim NEW BENZO HETEROCYCLES
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE3743265A1 (en) * 1987-12-19 1989-06-29 Boehringer Ingelheim Kg NEW AMMONIUM COMPOUNDS, THEIR MANUFACTURE AND USE
US5502078A (en) * 1991-05-28 1996-03-26 Zeneca Limited Chemical compounds
JPH0912518A (en) * 1995-06-26 1997-01-14 Kanegafuchi Chem Ind Co Ltd Production of 2-(1-(3'4'-dimethoxyphenlyl)-2-propyamino)-1-(3'-chloropheml)-ethanol
JPH11255743A (en) * 1998-03-06 1999-09-21 Dainippon Pharmaceut Co Ltd Production of optically active indole derivative and intermediate for producing the same
OA12403A (en) 2000-10-12 2006-04-18 Boehringer Ingelheim Pharma Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament.
IL156548A0 (en) * 2000-12-21 2004-01-04 Aventis Pharma Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
BR0210537A (en) 2001-06-22 2004-06-22 Boehringer Ingelheim Pharma Crystalline anticholinergic, process for its preparation and its application for the preparation of a medicine
DE10253282A1 (en) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treatment of chronic obstructive pulmonary disease, using new or known N-substituted 2-amino-1-(benz-(1,4)-oxazin-3-on-8-yl)-ethanol derivative beta-mimetic agents, suitable for once-daily administration
WO2005110990A1 (en) * 2004-05-13 2005-11-24 Boehringer Ingelheim International Gmbh Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases

Also Published As

Publication number Publication date
DE102004024454A1 (en) 2005-12-08
PT1789405E (en) 2013-08-22
PL1789405T3 (en) 2013-12-31
CN106995414A (en) 2017-08-01
WO2005111005A1 (en) 2005-11-24
EP1789405A1 (en) 2007-05-30
CA2562859A1 (en) 2005-11-24
NZ551416A (en) 2011-04-29
CN106146425A (en) 2016-11-23
AU2005243469A1 (en) 2005-11-24
CN101133039A (en) 2008-02-27
DK1789405T3 (en) 2013-10-14
IL179217A0 (en) 2007-03-08
KR20070011602A (en) 2007-01-24
RU2378262C2 (en) 2010-01-10
ES2431118T3 (en) 2013-11-25
EP1789405B1 (en) 2013-07-17
CN102827097A (en) 2012-12-19
JP2007537196A (en) 2007-12-20
CN102827097B (en) 2016-11-23
BRPI0511102B1 (en) 2021-05-25
CA2562859C (en) 2012-05-08
SI1789405T1 (en) 2013-09-30
MXPA06013218A (en) 2007-02-08
CY1114702T1 (en) 2016-10-05
RU2006144123A (en) 2008-09-10
BRPI0511102A (en) 2007-11-27
IL179217A (en) 2012-08-30
KR101270447B1 (en) 2013-06-04
AU2005243469B2 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
ZA200607152B (en) Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
IL181008A0 (en) Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
IL176913A0 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
HK1088037A1 (en) Methods for the production of insulin in plants
PL1757582T3 (en) Arylalkylamines and process for production thereof
IL180874A0 (en) Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments
IL180897A0 (en) Method of producing a composition, composition and its use
PL378065A1 (en) Substituted n-arylheterocycles, method for production and use thereof as medicaments
IL185804A0 (en) Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
IL177087A0 (en) Controlled-release pharmaceutical composition and method for producing the same
ZA201001015B (en) (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
IL204556A0 (en) (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
EP1820538A4 (en) Cosmetics and process for production thereof
IL179170A0 (en) Novel substituted thiophenecarboxamides, their production and their use as medicaments
IL180954A0 (en) Nanoparticles and method for the production thereof
IL228730A0 (en) Pharmaceutical manufacturing process
EP1731139A4 (en) S/o type pharmaceutical preparation and process for producing the same
ZA200703376B (en) Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals
IL183395A0 (en) Meta-substituted thiazolidinones, the production thereof and their use as medicaments
EP1781773A4 (en) A micro-organism and a method of producing paclitaxel by the use of the same
ZA200710146B (en) New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
PT1763515E (en) 4-trifluoromethoxyphenoxybenzol-4`-sulfonic acids, method for the production and use thereof in medicaments
ZA200705782B (en) Meta-substituted thiazolidinones, the production thereof and their use as medicaments
ZA200710147B (en) New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents